CRRT treatment techniques
Conditions
Interventions
the citrate group:a sodium citrate solution (physiological sodium chloride 970 ml + 4% sodium citrate 30 ml) was used to prime the circuit,
the heparin group:a heparin solution (heparin 25 mg in physiological sodium chloride 1000 ml, Baxter, Deerfield, IL, USA) was used to prime the circuit before CVVH was performed
the saline group:he pipeline was primed first with heparin saline (heparin 25 mg in physiological sodium chloride 1000 ml, Baxter, Deerfield, IL, USA) and then with 250 ml of saline before CVVH was pe
Sponsors
The Second Affiliated Hospital of Hainan Medical College
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. ARF patients who need CRRT or CRF and maintenance hemodialysis patients; 2. Accompanied by one of the following conditions: 1) Acute pulmonary edema; 2) Hemodynamic instability; 3) Renal edema; 4) Hydrothorax and ascites.
Exclusion criteria
Exclusion criteria: 1.2, activated partial thromboplastin time (APTT)>60 seconds, or bleeding within 24 hours.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the coagulation function;platelets;The coagulation degree of the filters; | — |
Secondary
| Measure | Time frame |
|---|---|
| electron microscopy;The citrate dosage;the decrease in serum creatinine;the decrease in blood urea nitrogen; | — |
Countries
China
Contacts
Public ContactHuiling Gan
Xiangya Hospital of Central South University
Outcome results
None listed